Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Glutathione (GSH) In The Treatment of Parkinson's Disease

This study has been completed.
Wellness Health & Pharmaceuticals, Inc.
Information provided by:
University of South Florida Identifier:
First received: August 5, 2010
Last updated: August 6, 2010
Last verified: January 2007
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)